These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36512100)

  • 1. Role of senescent tumor cells in building a cytokine shield in the tumor microenvironment: mathematical modeling.
    Kim Y; Lee J; Lee C; Lawler S
    J Math Biol; 2022 Dec; 86(1):14. PubMed ID: 36512100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer.
    Choi YW; Kim YH; Oh SY; Suh KW; Kim YS; Lee GY; Yoon JE; Park SS; Lee YK; Park YJ; Kim HS; Park SH; Kim JH; Park TJ
    Adv Sci (Weinh); 2021 Feb; 8(4):2002497. PubMed ID: 33643790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senescent tumor cells: an overlooked adversary in the battle against cancer.
    Park SS; Choi YW; Kim JH; Kim HS; Park TJ
    Exp Mol Med; 2021 Dec; 53(12):1834-1841. PubMed ID: 34916607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL12 Signaling in the Tumor Microenvironment.
    Portella L; Bello AM; Scala S
    Adv Exp Med Biol; 2021; 1302():51-70. PubMed ID: 34286441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-helper 2 cytokines attenuate senescent eosinophil activation by the CXCR4 ligand stromal-derived factor-1alpha (CXCL12).
    Dulkys Y; Buschermöhle T; Escher SE; Kapp A; Elsner J
    Clin Exp Allergy; 2004 Oct; 34(10):1610-20. PubMed ID: 15479278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment.
    Zeng Y; Li B; Liang Y; Reeves PM; Qu X; Ran C; Liu Q; Callahan MV; Sluder AE; Gelfand JA; Chen H; Poznansky MC
    FASEB J; 2019 May; 33(5):6596-6608. PubMed ID: 30802149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of cellular chemotaxis with ECIS/Taxis.
    Pietrosimone KM; Yin X; Knecht DA; Lynes MA
    J Vis Exp; 2012 Apr; (62):. PubMed ID: 22491349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma.
    Kitawaki Y; Nakamura Y; Kubota-Nakayama F; Yamazaki Y; Miki Y; Hata S; Ise K; Kikuchi K; Morimoto R; Satoh F; Sasano H
    Hum Pathol; 2018 Jul; 77():88-97. PubMed ID: 29596893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity.
    D'Agostino G; Cecchinato V; Uguccioni M
    Front Immunol; 2018; 9():2185. PubMed ID: 30319638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular senescence and the tumour microenvironment.
    Takasugi M; Yoshida Y; Ohtani N
    Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Tumor Microenvironment in Glioblastoma: A Mathematical Model.
    Kim Y; Jeon H; Othmer H
    IEEE Trans Biomed Eng; 2017 Mar; 64(3):519-527. PubMed ID: 27959794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment.
    Santagata S; Ieranò C; Trotta AM; Capiluongo A; Auletta F; Guardascione G; Scala S
    Front Oncol; 2021; 11():591386. PubMed ID: 33937018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketogenesis Attenuates KLF5-Dependent Production of CXCL12 to Overcome the Immunosuppressive Tumor Microenvironment in Colorectal Cancer.
    Wei R; Zhou Y; Li C; Rychahou P; Zhang S; Titlow WB; Bauman G; Wu Y; Liu J; Wang C; Weiss HL; Evers BM; Wang Q
    Cancer Res; 2022 Apr; 82(8):1575-1588. PubMed ID: 35247887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
    Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
    J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
    Jiang YP; Wu XH; Xing HY; DU XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach.
    Kim E; Rebecca V; Fedorenko IV; Messina JL; Mathew R; Maria-Engler SS; Basanta D; Smalley KS; Anderson AR
    Cancer Res; 2013 Dec; 73(23):6874-85. PubMed ID: 24080279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
    Daniel SK; Seo YD; Pillarisetty VG
    Semin Cancer Biol; 2020 Oct; 65():176-188. PubMed ID: 31874281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescence-Associated Molecules and Tumor-Immune-Interactions as Prognostic Biomarkers in Colorectal Cancer.
    Kellers F; Fernandez A; Konukiewitz B; Schindeldecker M; Tagscherer KE; Heintz A; Jesinghaus M; Roth W; Foersch S
    Front Med (Lausanne); 2022; 9():865230. PubMed ID: 35492321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.
    D'Alterio C; Buoncervello M; Ieranò C; Napolitano M; Portella L; Rea G; Barbieri A; Luciano A; Scognamiglio G; Tatangelo F; Anniciello AM; Monaco M; Cavalcanti E; Maiolino P; Romagnoli G; Arra C; Botti G; Gabriele L; Scala S
    J Exp Clin Cancer Res; 2019 Oct; 38(1):432. PubMed ID: 31661001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients.
    Mosadegh B; Saadi W; Wang SJ; Jeon NL
    Biotechnol Bioeng; 2008 Aug; 100(6):1205-13. PubMed ID: 18553401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.